C. Quinn

C. Quinn, N. Wright, 1992, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast

C. Quinn, A. Rice, A Rice, 2002, Journal of clinical pathology.

A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.

J. Geraghty, E. McDermott, C. Quinn, 2015, Breast.

The classification of invasive carcinoma of the breast

C. Quinn, M. Cotter, Louisa M Gannon, 2013, Expert review of anticancer therapy.

differentiated hepatocellular carcinoma with unusual tubular structures

C. Quinn, D. Gibbons, K. H. A Jubb, 2005 .

Specific cell differentiation in breast cancer: a basis for histological classification

E. Rakha, C. Quinn, M. Toss, 2021, Journal of Clinical Pathology.

How current assay approval policies are leading to unintended imprecision medicine.

T. Nielsen, D. Rimm, C. Quinn, 2020, The Lancet. Oncology.

Where youth matters—clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer

E. McDermott, C. Quinn, J. Crown, 2019, Irish Journal of Medical Science (1971 -).

Atypia in breast pathology: what pathologists need to know.

I. Ellis, E. Rakha, C. Quinn, 2021, Pathology.

Impact of receptor phenotype on nodal burden in patients with breast cancer who have undergone neoadjuvant chemotherapy

M. Kerin, E. McDermott, C. Quinn, 2017, BJS open.

Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.

P. Querzoli, F. Poli, C. Quinn, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Predictive Value of Breast Lesions of “Uncertain Malignant Potential” and “Suspicious for Malignancy” Determined by Needle Core Biopsy

M. Dillon, E. McDermott, C. Quinn, 2007, Annals of Surgical Oncology.

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis

I. Ellis, P. V. van Diest, E. Rakha, 2021, Cancers.

Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance

I. Ellis, E. Rakha, C. Quinn, 2021, Histopathology.

Eighth Edition Cancer Staging Manual of Breast Cancer by the American Joint Committee on Cancer: are the new changes to improve staging or a treatment decision tool?

E. Rakha, C. Quinn, 2018, Journal of Clinical Pathology.

Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast

C. Quinn, C. D’Arcy, 2018, Journal of Clinical Pathology.

Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland

J. Geraghty, C. Quinn, J. Crown, 2021, Breast Cancer Research and Treatment.

Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer

C. Quinn, M. Cotter, B. Dunne, 2017, Virchows Archiv.

Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland

C. Quinn, B. Hennessy, M. Keane, 2015, Breast Cancer Research and Treatment.

Investigation of molecular alterations of AKT‐3 in triple‐negative breast cancer

Yue Fan, Gillian O'Hurley, Anthony O'Grady, 2014, Histopathology.

Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases

I. Ellis, E. Provenzano, S. Pinder, 2021, British Journal of Cancer.

Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative

X. Castells, H. Schünemann, A. Torresin, 2021, British Journal of Cancer.

Prognostic impact of macrometastasis linear size in sentinel node biopsy for breast carcinoma.

C. Quinn, P. Regitnig, S. Bianchi, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Magnetic resonance imaging appearances in primary and secondary angiosarcoma of the breast

E. McDermott, C. Quinn, A. O'Doherty, 2014, Journal of medical imaging and radiation oncology.

Reporting of Surgically Removed Lymph Nodes for Breast Tumors: Recommendations From the International Collaboration on Cancer Reporting.

P. Tan, G. Farshid, E. Provenzano, 2022, Archives of pathology & laboratory medicine.

Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions.

P. V. van Diest, C. Quinn, P. Regitnig, 2011, European journal of cancer.

The Accuracy of Ultrasound, Stereotactic, and Clinical Core Biopsies in the Diagnosis of Breast Cancer, With an Analysis of False-Negative Cases

Niall O'Higgins, M. Dillon, E. McDermott, 2005, Annals of surgery.

Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study

P. Heikkilä, C. Quinn, P. Regitnig, 2018, Breast Cancer Research and Treatment.

The Value of Isosulfan Blue Dye in Addition to Isotope Scanning in the Identification of the Sentinel Lymph Node in Breast Cancer Patients With a Positive Lymphoscintigraphy: A Randomized Controlled Trial (ISRCTN98849733).

J. Geraghty, E. McDermott, C. Quinn, 2015, Annals of surgery.

Squamous cell carcinoma of the maxillary antrum metastatic to the heart and skin

C. Quinn, R. Calvert, 1994, The Journal of Laryngology & Otology.

Axillary fine needle aspiration cytology for pre-operative staging of patients with screen-detected invasive breast carcinoma

C. Quinn, A. O'Doherty, F. Flanagan, 2011, Journal of Clinical Pathology.

Human Epidermal Growth Factor Receptor 2 Testing by Fluorescent In Situ Hybridization: Positive or Negative? ASCO/College of American Pathologists Guidelines 2007, 2013, and 2018.

C. Quinn, G. Gullo, L. Flanagan, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The American Joint Commission Cancer 8th Edition Prognostic Stage Including Oncotype DX® Recurrence Score: Impact on Staging of Early Breast Cancer

E. McDermott, C. Quinn, R. Prichard, 2018, Pathobiology.

Clinicopathologic features of sentinel node metastases predictive of positive axillary clearance in grade 1 invasive breast carcinoma

C. Quinn, O. Mc Cormack, B. Hayes, 2009, Irish journal of medical science.

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

Andrew H. Beck, Clare C. Yu, M. N. Vidya, 2021, npj Breast Cancer.

Factors Affecting Successful Breast Conservation for Ductal Carcinoma in Situ

M. Dillon, C. Quinn, A. O'Doherty, 2007, Annals of surgical oncology.

Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer

C. Quinn, J. Crown, S. Furney, 2020, British Journal of Cancer.

Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markers

C. Quinn, P. Regitnig, A. Sapino, 2016, Virchows Archiv.

The pathology of breast screening

C. Quinn, 2001 .

A Pathologic Assessment of Adequate Margin Status in Breast-Conserving Therapy

M. Dillon, E. McDermott, C. Quinn, 2006, Annals of surgical oncology.

Needle core biopsy characteristics identify patients at risk of compromised margins in breast conservation surgery

M. Dillon, E. McDermott, C. Quinn, 2008, Modern Pathology.

Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators

S. Duffy, X. Castells, H. Schünemann, 2020, BMC Cancer.

Can the synthetic C view images be used in isolation for diagnosing breast malignancy without reviewing the entire digital breast tomosynthesis data set?

C. Quinn, R. Prichard, A. O’Neill, 2018, Irish Journal of Medical Science (1971 -).

Invasive ductal carcinoma accompanied by ductal carcinoma in situ (DCIS): comparison of DCIS grade with grade of invasive component

C. Quinn, J. Ostrowski, B. Cadman, 1997 .

High‐Grade Histologic Features of DCIS are Associated with R5 Rather than R3 Calcifications in Breast Screening Mammography

C. Quinn, A. O'Doherty, B. Hayes, 2013, The breast journal.

Terminology for carcinoma-in-situ of the breast

M. Stratton, C. Quinn, J. Sloane, 1996, The Lancet.

Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma.

M. Dillon, E. McDermott, C. Quinn, 2006, American journal of surgery.

Epithelial displacement during breast needle core biopsy causes diagnostic difficulties in subsequent surgical excision specimens

C. Quinn, A. O'Doherty, Sine Phelan, 2006, Journal of Clinical Pathology.

Liesegang rings in inflammatory breast lesions.

C. Quinn, D. Gibbons, N. Banville, 2005, Journal of clinical pathology.

False‐negative rate of ultrasound‐guided fine‐needle aspiration cytology for identifying axillary lymph node metastasis in breast cancer patients

H. Heneghan, J. Geraghty, E. McDermott, 2019, The breast journal.

Fine-Needle Aspiration Biopsy Management of the Axilla in Primary Breast Carcinoma

C. Quinn, D. Gibbons, C. Gibbons, 2019, Acta Cytologica.

Solid papillary carcinoma of the breast.

C. Quinn, J. Ostrowski, 1997, The American journal of surgical pathology.

Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice

M. Dillon, E. McDermott, C. Quinn, 2006, Journal of Clinical Pathology.

UK recommendations for HER2 assessment in breast cancer: an update

I. Ellis, P. Tan, E. Provenzano, 2022, Journal of Clinical Pathology.

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer

I. Ellis, E. Provenzano, S. Pinder, 2021, Modern Pathology.

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations

E. Provenzano, P. Heikkilä, C. Quinn, 2023, Cancers.

Accuracy of classification of invasive lobular carcinoma on needle core biopsy of the breast

T. Stephenson, S. Pinder, C. Quinn, 2016, Journal of Clinical Pathology.

Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer

E. Provenzano, P. Heikkilä, C. Quinn, 2021, Cancers.

The value of mitotic counting in the assessment of prognosis and proliferation in human tumours

Y. Collan, C. Quinn, N. Wright, 1991, The Journal of pathology.

"Exosomes as Biomarkers of Human and Feline Mammary Tumours; A Comparative Medicine Approach to Unravelling the Aggressiveness of TNBC".

C. Quinn, D. Argyle, A. McCann, 2020, Biochimica et biophysica acta. Reviews on cancer.

Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?

C. Quinn, P. Regitnig, S. Bianchi, 2017, Pathology & Oncology Research.

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the “one thousand HER2 patients” project

J. Geraghty, E. McDermott, C. Quinn, 2018, British Journal of Cancer.

Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011.

J. Geraghty, E. McDermott, C. Quinn, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

PARP1 in triple-negative breast cancer: Expression and therapeutic potential.

E. McDermott, C. Quinn, J. Crown, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The approach to an isolated close anterior margin in breast conserving surgery

J. Geraghty, E. McDermott, C. Quinn, 2019, Annals of the Royal College of Surgeons of England.

Chromosome X aneusomy and androgen receptor gene copy number aberrations in apocrine carcinoma of the breast

C. Quinn, A. Sanchez, R. Masetti, 2021, Virchows Archiv.

Management of B3 Lesions and Breast Biopsies

M. Dillon, C. Quinn, E. M. Mc Dermott, 2008, Annals of Surgical Oncology.

Multisystem Langerhans' cell histiocytosis with pancreatic involvement.

C. Quinn, R. Yu, A. Chu, 1993, Gut.

Nodal-stage classification in invasive lobular breast carcinoma: influence of different interpretations of the pTNM classification.

P. V. van Diest, C. Quinn, A. Sapino, 2010, Journal of Clinical Oncology.

Ductal carcinoma in situ of the breast: the clinical significance of histological classification

C. Quinn, K. Horgan, C. Quinn, 1997, Histopathology.

Factors affecting metastases to non-sentinel lymph nodes in breast cancer

E. McDermott, C. Quinn, N. O’higgins, 2003, Journal of clinical pathology.

Essential parameters in breast cancer: histopathology reporting guidelines.

C. Quinn, T. Lioe, 2002, Irish medical journal.

mTOR in breast cancer: differential expression in triple-negative and non-triple-negative tumors.

E. McDermott, C. Quinn, M. Duffy, 2012, Breast.

Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011.

J. Geraghty, E. McDermott, C. Quinn, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.